Search research articles
Contact Us
Filters
Showing results (51-60 of 59) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 59 results.
Acta Medica Austriaca
|
January 1, 1995
[Effect of dexfenfluramine on eating behavior and body weight of obese patients: results of a field study of Isomeride in Austrian general practice]
G Geyer, G Haidinger, M Francesconi, et al.
Acta Medica Austriaca
|
January 1, 1995
[Increased prevalence of serum IgA Chlamydia antibodies in obesity]
H Toplak, T C Wascher, K Weber, et al.
Journal of Inherited Metabolic Disease
|
January 1, 1995
Severely depressed natural killer cell activity of patients with adrenoleukodystrophy under treatment with Lorenzo's oil
P Sedlmayr, B Plecko, E Paschke, et al.
Diabetes Research and Clinical Practice
|
April 1, 1996
Increased prevalence of IgA-Chlamydia antibodies in NIDDM patients
H Toplak, E M Haller, T Lauermann, et al.
Diabetes, Obesity & Metabolism
|
October 13, 2005
X-PERT: weight reduction with orlistat in obese subjects receiving a mildly or moderately reduced-energy diet: early response to treatment predicts weight maintenance
H Toplak, O Ziegler, U Keller, et al.
European Journal of Endocrinology
|
December 20, 2019
European Society of Endocrinology Clinical Practice Guideline: Endocrine work-up in obesity
R Pasquali, F Casanueva, M Haluzik, et al.
European Journal of Endocrinology
|
October 26, 2019
Prevalence of endocrine disorders in obese patients: systematic review and meta-analysis
L T van Hulsteijn, R Pasquali, F Casanueva, et al.
European Journal of Clinical Investigation
|
June 3, 1999
Effects of intensified lifestyle modification on the need for further revascularization after coronary angioplasty
S Wallner, N Watzinger, M Lindschinger, et al.
Der Internist
|
April 29, 2014
[New AHA and ACC guidelines on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk : Statement of the D•A•CH Society for Prevention of Cardiovascular Diseases, the Austrian Atherosclerosis Society and the Working Group on Lipids and Atherosclerosis (AGLA) of the Swiss Society for Cardiology]
G Klose, F U Beil, H Dieplinger, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 59) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 59 results.
Acta Medica Austriaca
|
January 1, 1995
[Effect of dexfenfluramine on eating behavior and body weight of obese patients: results of a field study of Isomeride in Austrian general practice]
G Geyer, G Haidinger, M Francesconi, et al.
Acta Medica Austriaca
|
January 1, 1995
[Increased prevalence of serum IgA Chlamydia antibodies in obesity]
H Toplak, T C Wascher, K Weber, et al.
Journal of Inherited Metabolic Disease
|
January 1, 1995
Severely depressed natural killer cell activity of patients with adrenoleukodystrophy under treatment with Lorenzo's oil
P Sedlmayr, B Plecko, E Paschke, et al.
Diabetes Research and Clinical Practice
|
April 1, 1996
Increased prevalence of IgA-Chlamydia antibodies in NIDDM patients
H Toplak, E M Haller, T Lauermann, et al.
Diabetes, Obesity & Metabolism
|
October 13, 2005
X-PERT: weight reduction with orlistat in obese subjects receiving a mildly or moderately reduced-energy diet: early response to treatment predicts weight maintenance
H Toplak, O Ziegler, U Keller, et al.
European Journal of Endocrinology
|
December 20, 2019
European Society of Endocrinology Clinical Practice Guideline: Endocrine work-up in obesity
R Pasquali, F Casanueva, M Haluzik, et al.
European Journal of Endocrinology
|
October 26, 2019
Prevalence of endocrine disorders in obese patients: systematic review and meta-analysis
L T van Hulsteijn, R Pasquali, F Casanueva, et al.
European Journal of Clinical Investigation
|
June 3, 1999
Effects of intensified lifestyle modification on the need for further revascularization after coronary angioplasty
S Wallner, N Watzinger, M Lindschinger, et al.
Der Internist
|
April 29, 2014
[New AHA and ACC guidelines on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk : Statement of the D•A•CH Society for Prevention of Cardiovascular Diseases, the Austrian Atherosclerosis Society and the Working Group on Lipids and Atherosclerosis (AGLA) of the Swiss Society for Cardiology]
G Klose, F U Beil, H Dieplinger, et al.
Page
of 6